STAA - Company ID 0000718937
The table below shows STAAR SURGICAL CO's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $93.52M | $94.73M | $44.32M | $42.59M | $88.59M | $99.00M |
| Cost of revenue | $24.66M | $16.86M | $11.52M | $14.58M | $20.10M | $20.59M |
| Gross profit | $68.86M | $77.88M | $32.80M | $28.00M | $68.49M | $78.41M |
| R&D | $9.93M | $9.21M | $10.26M | $11.34M | $12.25M | $11.87M |
STAAR SURGICAL CO reported annual revenue of $239.44M for fiscal year 2026. That is down 23.7% from $313.90M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $82.43M (FY 2016) to $239.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $60.88M | $59.38M | $62.76M | $85.41M | $62.80M | $66.51M |
| Operating income | $7.98M | $18.49M | -$29.96M | -$57.40M | $5.68M | $11.90M |
| Income tax | $3.01M | $9.91M | -$9.10M | -$275.00K | $3.18M | $2.96M |
| Net income | $5.21M | $8.88M | -$16.81M | -$54.21M | $9.98M | $7.38M |
| EPS (diluted) | $0.10 | $0.18 | -$0.34 | -$1.10 | $0.20 | $0.15 |